• Redx Pharma CEO Lisa Anson appears in the Telegraph’s International Women’s Day feature

    Read more
  • Lisa Anson talks about new in vivo data indicating the broad potential of ROCK2 inhibitor in fibrosis (Video)

    Read more
  • Redx Pharma receives approval to re-commence clinical trial of RXC004 (Proactiveinvestors.co.uk)

    Read more
  • CSO Richard Armer outlines development ambitions and clinical targets (Video)

    Read more